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Abstract 
We report on the development of an uncommon association of pathologic processes, where 
an invasive adenocarcinoma of the breast developed concomitantly with a primary lymphoma 
arising in the same breast. The patient, a 78 year old female, presented with two palpable 
breast lesions in her left breast and an additional lesion in the right breast. Core needle bi-
opsies of the lesions revealed both ductal carcinoma and lymphoma existing adjacent to each 
other in the left breast and a second primary lymphoma in her right breast. The mammogram, 
which also defined the lesions, illustrated collision tumors of the left breast and a separate 
pathologic process in the right breast. Excision of the lesions confirmed the two independent 
lesions on the left side, one an infiltrating ductal carcinoma and the second a large B-cell 
lymphoma. Biopsy of the right breast also demonstrated existence of a large B-cell lymphoma. 
Left axillary biopsy using sentinel node technology indicated that there was no evidence of 
nodal metastasis. The question arose as to possible etiologic factors related to viral trans-
fection at the DNA level, that could cause transformation within the ductal epithelium of the 
breast with similar transfection of the lymphocytes of an adjacent intramammary node, that 
led to the development of the simultaneous pathologic processes of ductal carcinoma and 
B-cell lymphoma, defined on biopsy. 
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Case 
A 78 year old female presented to her primary 
care physician with a palpable lesion noted in her left 
breast, questionable axillary nodes and a second le-
sion in her right breast. The patient had no prior his-
tory of any medical or surgical illnesses and was not 
on  any  medication.  A  mammogram  taken  of  both 
breasts  revealed  approximating  lesions  in  the  left 
breast (Fig. 1) and a single lesion in the right breast.  
In Figure 1, we are able to discern two discrete 
lesions of the left breast the nature of which were de-
fined by core biopsy. The initial core biopsies of all 
three lesions were performed in the mammography 
department of North Shore Univ Hospital. The right 
breast proved to have a solitary lesion demonstrating 
predominantly  lymphocytic  pathology  consistent 
with a B cell lymphoma. In the left breast 2 separate 
pathologic processes were defined, one an infiltrating 
ductal carcinoma (Fig. 2a, 2b) and in close proximity, 
a second lesion, the B-cell lymphoma (Fig 3a, 3b). No 
further  surgery  was  performed  on  the  right  breast. 
The left breast underwent partial mastectomy. Nodes 
that were sampled from the left axilla were all nega-
tive.  Journal of Cancer 2011, 2 
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Figure 1 Demonstrates localization of two lesions of the left breast for biopsy. 
 
Figure 2. a). Poorly differentiated ductal Carcinoma obtained from a biopsy of the left breast carcinoma. b). High power 
view of the invasive ductal carcinoma obtained from the left breast x20. Journal of Cancer 2011, 2 
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Figure 3. a). Lymphoid pattern of the second lesion found in the left breast. b). Large B cell Lymphoma well defined on 
higher magnification x40. 
 
Pathology 
The initial core biopsies followed by the surgi-
cally  resected  specimens  taken  from  the  left  breast 
were subjected to routine H&E as well as immuno-
histochemical staining. PCR of tumor samples taken 
from the left breast were performed suggesting that 
the presence of a sequence derived MMTV was pre-
sent  in  the  specimen.  PET  scan  taken  shortly  after 
surgery, failed to demonstrate any evidence of distant 
pathology.  The  patient  was  seen  3  months  later  in 
follow up with the new finding of a mass on her back 
and swelling in the right popliteal space. Excisional 
biopsies of both new sites were performed. Each of 
the lesions proved to be consistent with B-cell lym-
phoma.  
Pathologic  evaluation  of  the  submitted  breast 
specimens revealed that the left breast contained the 
two discrete, but closely adjacent lesions measuring 
approximately  0.9  cm  in  diameter.  Microscopically 
there were determined to be both infiltrating ductal 
carcinoma in one and large B-cell lymphoma of fol-Journal of Cancer 2011, 2 
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licular cell origin in the second specimen. The right 
breast, back lesion and popliteal mass all presented 
with the histologic pattern of malignant B-cell lym-
phoma. 
Immunohistochemical studies revealed that the 
ductal carcinoma was ER+/PR+ and Her-2 negative. 
The lymphoma contained medium to large monoclo-
nal  B  cells  positive  for  CD45,  CD19,  CD20,  CD10, 
BCL-2,  BCL-6  kappa+/lambda-.  The  lymphomatous 
lesions were all negative for CD5, CD10, and CD23. 
Based on these findings the patient was not of-
fered therapy for the adenocarcinoma but was started 
immediately on CHOPP chemotherapy and Rituxan. 
These  medications  have  kept  the  lymphoma  under 
control  and  no  evidence  of  recurrence  of  or  a  new 
breast primary has been seen. 
Discussion 
Primary  lymphoma  of  the  breast  is  a 
well-known, albeit an uncommon form of breast can-
cer  comprising  only  0.04  to  0.5%  of  primary  breast 
malignancies (3,4,5). For the most part it arises within 
intramammary lymphoid tissue (6). The association of 
lymphoma  and  carcinoma  co-existing  in  the  same 
breast  is  less  frequently  seen  (7).  From  an  etiologic 
cause and relationship however, it is well known that 
the MMTV virus in particular, has a strong association 
with  breast  malignancy  (8)  and  is  beginning  to  be 
recognized as a potential etiologic factor in lymphoma 
and prostate cancer as well (9,10). Lymphocytes and 
in  particular  B  cells,  express  the  Wnt-1  gene  which 
serve to increase phosphorylation of B-catenin within 
the  cytoplasm  of  the  lymphocyte.  As  one  finds  in 
those cells lining the breast duct system, and in par-
ticular their precursor stem cells (11,12), transfection 
of the Wnt-1 gene in the ductal cells occurs via a viral 
fragment from the long terminal repeat (LTR) of the 
virus. This viral fragment enters the duct lining in a 
similar  fashion  to  that  in  which  the  lymphocyte  is 
transfected. Over expression of Wnt-1 occurs in both 
instances and leads to the development of ductal car-
cinoma  as  well  as  lymphoma  (13).  In  the  case  pre-
sented here, we believe that viral involvement of the 
glandular element of her breast tissue (probably via 
stem  cells)  synchronously  effected  the  adjacent  in-
tramammary  lymph  tissue  to  result  in  the  clinical 
findings noted.  
When the MMTV virus does transfect breast ep-
ithelial  tissue,  it  appears  that  this  virus  frequently 
involves,  as  mentioned  above,  the  Wnt-1  gene.  The 
effect of such a gene modification results in modula-
tion and as such, over expression of B-catenin within 
the  breast  cell  as  well  as  lymphocyte  that  may  be 
present  within  the  intramammary  tissue.  A  similar 
association has been noted in prostate cancer where 
over-expression of B-catenin is also related to the viral 
transfection of prostate cells by the MMTV virus. The 
Wnt-1 gene in these instances enhances phosphoryla-
tion  of  B-catenin  to  increase  its  activity.  B-catenin 
serves in almost all cases as both as a cadherin as well 
as transcriptional protein.  
Bittner  (14)  had  originally  suggested  and  then 
demonstrated at a later date, that a virus was respon-
sible for the development of breast cancer in the ex-
perimental  mouse  model.  It  is  now  commonly  ac-
cepted that a similar phenomenon occurs in human 
breast cancer. It has also been suggested that while 
DNA transfection occurs for the most part from ex-
ogenous viral sequences arising in the mus domesti-
cus, that in rare events, endogenous sequences related 
to the MMTV may be passed from generation to gen-
eration.  
A  sequence  homologous  to  a  segment  of  the 
MMTV envelop gene (15), can be defined in 38% of 
patients with cancer of the breast. Whether it is the 
MMTV virus alone or this virus in association with 
another such as the EBV virus (16,17)  is under con-
sideration. The EBV virus does contain a homologous 
sequence to FGARAT which acts as a transcriptional 
protein in many high grade human malignancies. It 
also  serves  to  over  express  the  enzyme  telomerase 
which is essential for the prolongation in survival of 
the cancer cell. 
The MMTV virus additionally contains hormone 
responsive elements which may account for the viru-
lence of breast cancer in pregnancy and lactation (18). 
61% of breast cancers developing during pregnancy 
and  subsequent  lactation  contain  the  envelop  se-
quence for the MMTV virus (19). Human isolates also 
contain superantigen sequences which are functional 
and may contribute to the pathogenesis of the malig-
nancy (20). Stewart (21) suggested that the viral car-
rier for MMTV was a particular strain of mouse, the 
mus  domesticus.  This  species  is  found  to  occupy  a 
narrow  swath  through  central  Europe  and  where 
breast cancer is seen to develop most frequently. This 
species of mouse had expanded across the Atlantic, 
after the Black Plague, originally appearing in Eng-
land  and  then  spreading  to  the  New  World,  repre-
sented by the Americas and then on to Australia.  
During  the  well-known  mouse  plagues  which 
appear periodically in Australia and wherein observ-
ers describe the mountain sides near the wheat fields 
being harvested, as covered by millions of the mice, 
the incidence of breast cancer can be shown to signif-
icantly increase. This incidence of clinical disease does 
however revert to the normal incidence of 1 in 7 pa-
tients when the plague has resolved. Journal of Cancer 2011, 2 
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Several  reports  have  appeared  illustrating  the 
high  association  of  breast  cancer  with  subsequent 
lymphoma developing systemically (22). There have, 
in  addition,  been  several  situations  reported  where 
the  association  of  the  two  pathologic  processes  has 
appeared  in  the  same  breast  synchronously.  One 
could define the presence of a sequence from the long 
terminal repeat of the MMTV strain by PCR in breast 
samples from ductal carcinoma arising in the breast 
tissue as well as in lymphomatous tissue from intra-
mammary nodes.  
One of the questions arising from the finding of 
various stages of transformation seen during growth 
of the malignancy is which particular population of 
cells is involved in the mutagenic process (23). Here, 
one of the prevailing concepts suggests that in many 
instances, stem cells may have migrated to breast tis-
sue involved in the malignancy and may be the insti-
gators of the malignant phenotypic process. 
Evidence for the presence of stem cells in normal 
mammary tissue has been demonstrated. These cells, 
which rarely divide, persist throughout the reproduc-
tive life of the patient. They can be identified by radi-
olabeling cells in the breast tissue samples taken for 
the expression of the stem cell antigen Sca-1, CD24 
heat stable antigen, and CD-29 B-antigen. Those cells 
expressing the antigen arrays, appear to have the ca-
pability for expanded differentiation and colony for-
mation. In the mammary gland tissue of MMTV in-
fected transgenic mice, the CD29, CD24 population of 
cells are increased and mammary cell outgrowth be-
comes markedly hyperplastic in appearance suggest-
ing that genotypic transformation has occurred. There 
are also reports that the transgenes encoding compo-
nents  of  the  Wnt  signaling  pathway  preferentially 
induce mammary cancers from such progenitor stem 
cells. This further implicates MMTV and its associa-
tion with the presence of stem cells which act as the 
initiator  of  breast  malignancy  (YiLi,  Welm  B, 
Podsypanina K et. al.) (24). Expression of the Wnt-1 
proto-oncogene  in  mammary  glands  of  transgenic 
mice result in an expansion of a population of epithe-
lial cells which express the progenitor cell markers, 
keratin 6 and Sca-1. Subsequently, developing tumors 
express these markers and contain luminal epithelial 
and myoepithelial tumor cells that share a secondary 
mutation, the loss of PTEN. This further implies that 
they arose from a common progenitor.  
The presence of stem or progenitor cell markers 
in mammary tumors, as noted above, suggests that 
breast malignancies arise from immature cells. Two 
genes, keratin 6 and stem cell antigen (Sca-1) appear 
to be preferentially expressed in mammary stem and 
or  progenitor  cells  (22).  Keratin  6  is  expressed  in 
mammary gland analage at around embryonic day 16. 
Sca-1, encoded by Ly-6A/E is a GPI linked protein 
that is also found in hematopoietic stem cells. Deple-
tion of these cells results in a loss of functional stem 
cells in mammary gland reconstitution experiments. 
Sca-1 is not observed after cells have further differen-
tiated to express the progesterone receptor.  
Bittner (1,2,3) had originally suggested and then 
demonstrated that a virus carried by mouse was re-
sponsible  for  the  development  of  breast  cancer  in 
mice. Information is now commonly accepted that a 
sequence  homolgous  to  a  unique  segment  of  the 
MMTV  envelop  gene  can  be  defined  in  38%  of  pa-
tients with cancer of the breast (24). The MMTV virus 
contains  hormone  responsive  elements  which  may 
account  for  the  virulence  of  breast  cancer  in  preg-
nancy and lactation. 61% of breast cancers developing 
during pregnancy and lactation contain the envelop 
sequence for the virus. Human isolates also contain 
super  antigen  sequences  which  are  functional  and 
may  contribute  to  pathogenesis  of  the  malignancy. 
Stewart  (21)  suggested  that  the  viral  carrier  was  a 
strain of mouse, the mus domesticus, which occupies 
a  narrow  swath  through  central  Europe  and  where 
breast cancer is seen to develop most frequently. This 
species expanded across the Atlantic, originally from 
England and then to the New World represented by 
the  Americas  and  then  on  to  Australia.  During  the 
well-known  mouse  plagues  which  appear  periodi-
cally in Australia and wherein observers define the 
mountain sides as covered by millions of the mice, the 
incidence of breast cancer can be shown to increase, 
only to revert to the common incidence of 1 in 7 pa-
tients when the plague has resolved. 
Upregulation of SMYD3 (25), a histone H3 Ly-
sine 4 specific methyl transferanse, which plays a key 
role  in  the  proliferation  of  colorectal  cancer  is  also 
elevated in the majority of breast cancer cells. Silenc-
ing  of  SMYD3  by  small  iRNA  molecules  directed 
against the gene was found to inhibit the growth of 
breast cancer cells. SMYD3 also promotes the devel-
opment of breast carcinogenesis by directly regulating 
the expression the proto-oncogene WNT 10B. 
The leader peptide (p14) of the Env-precursor of 
the  MMTV  is  translocated  in  to  the  nucleoli  of  the 
murine T cell lymphomas that harbor the virus. P14 is 
also localized to the nucleoli of mammary carcinomas 
and some human breast cancer tissue specimens that 
have been studied. These findings further suggest that 
there is an association between the development of 
lymphoma and mammary carcinoma. 
Mouse  mammary  tumor  virus  like  sequences 
have been found in up to 40% of breast cancer sam-
ples  (26,  27).  32%  (43  0f  136)  female  breast  cancer Journal of Cancer 2011, 2 
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samples  were  positive  for  MMTV  like  sequences 
when screened by PCR. Grade 1 tumors had 34% in-
cidence  and  grade  3  a  38%  incidence.  MMTV  se-
quences were found in 62 (8 of 13) male breast cancer 
samples  and  10  of  52  (19%)  of  male  gynecomastia. 
Both MMTV and the putative human homolog of the 
virus have been shown to have hormone responsive 
elements in the long terminal repeat regions of their 
genomes suggest that for the induction of breast car-
cinogenesis an infection via the virus, hormone activ-
ity  and  genetic  elements  combine  to  initiate  trans-
formation to malignancy.  
Primary  lymphoma  of  the  breast  constitutes 
0.04% - 0.05% of breast neoplasms and 1.7% of all ex-
tranodal NHL (28,29,30). Its rarity is probably related 
to the small amount of lymphoid tissue in the breast. 
Responding  to  combined  therapy  for  intermediate 
grade lymphoma. 
MMTV is a B type retrovirus wherein infection 
allows viral  RNA to be released into the cells with 
additional proteins allowing for viral replication. Af-
ter  release  of  the  RNA,  the  reverse  transcriptase 
makes a DNA copy  which can be inserted into  the 
cellular DNA such as WNT-1. Many of these viruses 
become endogenous to the genome and then can be 
passed to the offspring. In mice with endogenous vi-
ral  DNA  and  the  incidence  of  the  malignancy  in-
creases. There may be both exogenous and endoge-
nous homolog’s of HMTV, Holland and Pogo (2,15). 
Gary (15), as noted above, also discovered a retrovirus 
which was more than 95% homologous in structure to 
MMTV  but  which  remains  endogenous  in  humans. 
He  had  also  shown  that  HMTV  sequences  can  be 
identified in about 90% of human breast cancer pa-
tients. 
The  possible  causative  viruses  related  to  most 
human malignancies and in particular breast cancer 
are B type retroviruses (31,32). The genome of these 
retroviruses  is  composed  of  RNA  which  when  re-
leased  into  the  cell  along  with  a  secondary  pro-
tein/enzyme, the reverse transcriptase, conversion to 
DNA occurs. This DNA copy is inserted in an at ran-
dom fashion into the DNA of the infected cell. These 
viral  sequences  then  direct  expression  of  the  viral 
genome  where  in  response  to  estrogen,  a  complete 
RNA  copy  of  the  viral  genome  is  produced.  Some-
times an at random insertion occurs within an area of 
the DNA base pairing that results in alteration of the 
gene function. These series of mutations, almost all 
arising from transfection with the MMTV retrovirus, 
allows  progressive  transformation  leading  to  the 
clinical  development  of  breast  cancer  and  the  occa-
sional case of breast lymphoma. 
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